Story at a glance  Alzheimer’s disease affects 5 million people in the U.S., according to data from 2020. Researchers are working to understand the various risk factors that may contribute to …

cross-posted from: https://exploding-heads.com/post/45106

“This discovery opens exciting new directions for developing precision medicine-based therapies for Alzheimer’s disease, focusing on SHMOOSE as a target area,” said Pinchas Cohen, a professor of gerontology, medicine and biological sciences and senior author of the study, in a press release. “Administration of SHMOOSE analogs in individuals who carry the mutation and produce the mutant protein may prove to have benefit in neurodegenerative and other diseases of aging.”